Literature DB >> 15456752

Modes of caldesmon binding to actin: sites of caldesmon contact and modulation of interactions by phosphorylation.

D Brian Foster1, Renjian Huang, Victoria Hatch, Roger Craig, Philip Graceffa, William Lehman, C-L Albert Wang.   

Abstract

Smooth muscle caldesmon binds actin and inhibits actomyosin ATPase activity. Phosphorylation of caldesmon by extracellular signal-regulated kinase (ERK) reverses this inhibitory effect and weakens actin binding. To better understand this function, we have examined the phosphorylation-dependent contact sites of caldesmon on actin by low dose electron microscopy and three-dimensional reconstruction of actin filaments decorated with a C-terminal fragment, hH32K, of human caldesmon containing the principal actin-binding domains. Helical reconstruction of negatively stained filaments demonstrated that hH32K is located on the inner portion of actin subdomain 1, traversing its upper surface toward the C-terminal segment of actin, and forms a bridge to the neighboring actin monomer of the adjacent long pitch helical strand by connecting to its subdomain 3. Such lateral binding was supported by cross-linking experiments using a mutant isoform, which was capable of cross-linking actin subunits. Upon ERK phosphorylation, however, the mutant no longer cross-linked actin to polymers. Three-dimensional reconstruction of ERK-phosphorylated hH32K indeed indicated loss of the interstrand connectivity. These results, together with fluorescence quenching data, are consistent with a phosphorylation-dependent conformational change that moves the C-terminal end segment of caldesmon near the phosphorylation site but not the upstream region around Cys(595), away from F-actin, thus neutralizing its inhibitory effect on actomyosin interactions. The binding pattern of hH32K suggests a mechanism by which unphosphorylated, but not ERK-phosphorylated, caldesmon could stabilize actin filaments and resist F-actin severing or depolymerization in both smooth muscle and nonmuscle cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456752     DOI: 10.1074/jbc.M410109200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Structure and dynamics of the actin-based smooth muscle contractile and cytoskeletal apparatus.

Authors:  William Lehman; Kathleen G Morgan
Journal:  J Muscle Res Cell Motil       Date:  2012-02-07       Impact factor: 2.698

2.  Structural basis for the regulation of muscle contraction by troponin and tropomyosin.

Authors:  Agnieszka Galińska-Rakoczy; Patti Engel; Chen Xu; Hyunsuk Jung; Roger Craig; Larry S Tobacman; William Lehman
Journal:  J Mol Biol       Date:  2008-05-03       Impact factor: 5.469

3.  Differential effects of caldesmon on the intermediate conformational states of polymerizing actin.

Authors:  Renjian Huang; Zenon Grabarek; Chih-Lueh Albert Wang
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

4.  Differential effects of thin and thick filament disruption on zebrafish smooth muscle regulatory proteins.

Authors:  G Davuluri; C Seiler; J Abrams; A J Soriano; M Pack
Journal:  Neurogastroenterol Motil       Date:  2010-06-28       Impact factor: 3.598

5.  Ablation of smooth muscle caldesmon affects the relaxation kinetics of arterial muscle.

Authors:  Hongqiu Guo; Renjian Huang; Shingo Semba; Jolanta Kordowska; Yang Hoon Huh; Yana Khalina-Stackpole; Katsuhide Mabuchi; Toshio Kitazawa; Chih-Lueh Albert Wang
Journal:  Pflugers Arch       Date:  2012-11-14       Impact factor: 3.657

6.  Ancient Use of Ig Variable Domains Contributes Significantly to the TCRδ Repertoire.

Authors:  Thaddeus C Deiss; Breanna Breaux; Jeannine A Ott; Rebecca A Daniel; Patricia L Chen; Caitlin D Castro; Yuko Ohta; Martin F Flajnik; Michael F Criscitiello
Journal:  J Immunol       Date:  2019-07-24       Impact factor: 5.422

Review 7.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

8.  Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.

Authors:  Qifeng Jiang; Renjian Huang; Shaoxi Cai; Chih-Lueh A Wang
Journal:  J Biomed Sci       Date:  2010-02-03       Impact factor: 8.410

9.  siRNA-mediated knockdown of h-caldesmon in vascular smooth muscle.

Authors:  Elaine M Smolock; Danielle M Trappanese; Shaohua Chang; Tanchun Wang; Paul Titchenell; Robert S Moreland
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

10.  Modulation of actin mechanics by caldesmon and tropomyosin.

Authors:  M J Greenberg; C-L A Wang; W Lehman; J R Moore
Journal:  Cell Motil Cytoskeleton       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.